AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT

British Journal of Pharmacology - Tập 60 Số 4 - Trang 537-545 - 1977
A. Cowan1,2, John W. Lewis1, Ian R. Macfarlane1
1Department of Pharmacology, Reckitt & Colman, Dansom Lane, Kingston-upon-Hull HU8 7DS
2Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, U.S.A.

Tóm tắt

1 Buprenorphine is a highly lipophilic derivative of oripavine. In rodent antinociceptive assays (writhing, tail pressure), buprenorphine had an action which was rapid in onset and of long duration; it was 25‐40 times more potent than morphine after parenteral injection and 7‐10 times more potent after oral administration.

2 The log dose‐response relationship for buprenorphine was curvilinear in mouse and rat tail flick tests with the antinociceptive effect decreasing at higher, non‐toxic doses.

3 Tolerance developed to the antinociceptive activity of buprenorphine in mice.

4 No signs of abstinence were observed on naloxone challenge or after abrupt withdrawal in monkeys receiving buprenorphine chronically for one month.

5 Buprenorphine antagonized the antinociceptive actions of morphine in mouse and rat tail flick tests but was an ineffective antagonist in the rat tail pressure test.

6 Buprenorphine precipitated signs of abstinence in morphine‐dependent mice and monkeys but not in morphine‐dependent rats.

7 Buprenorphine produced Straub tails in mice. This effect was not antagonized when the animals were pretreated with naloxone. However, in the rat tail pressure test high doses of diprenorphine antagonized established antinociceptive effects of buprenorphine.

8 It is concluded that buprenorphine represents a definite advance in the search for a narcotic antagonist analgesic of low physical dependence potential.

Từ khóa


Tài liệu tham khảo

ARIËNS E.J., 1957, Affinity, intrinsic activity and drug interactions, Pharmac. Rev., 9, 218

10.1007/BF00428791

10.1007/BF00421548

10.1111/j.1476-5381.1966.tb01910.x

COWAN A., 1974, Evaluation of the physical dependence capacities of oripavine‐thebaine partial agonists in patas monkeys, Adv. Biochem. Psychopharmac., 8, 427

10.1111/j.2042-7158.1976.tb04126.x

10.1111/j.1476-5381.1977.tb07533.x

COWAN A., 1971, Analgesic and dependence studies with oripavine partial agonists, Br. J. Pharmac., 43, 461

10.1016/B978-1-4832-2845-7.50013-X

DEWEY W.L., 1975, Blockade of the development of morphine dependence and substitution studies in rats, Pharmacologist, 17, 236

DEWEY W.L., 1970, The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail flick and phenylquinone tests, J. Pharmac. exp. Ther., 175, 435

FINNEY D.J., 1971, Probit Analysis, 100

HENDERSHOT L.C., 1959, Antagonism of the frequency of phenylquinone‐induced writhing in the mouse by weak analgesics and nonanalgesics, J. Pharmac. exp. Ther., 125, 237

10.1002/cpt197213178

10.1002/cpt1970113385

10.1016/0014-2999(75)90317-9

MARTIN W.R., 1976, The effects of morphine‐and nalorphine‐like drugs in the nondependent and morphine‐dependent chronic spinal dog, J. Pharmac. exp. Ther., 197, 517

MARTIN W.R. GILBERT P.E. EADES C.G. THOMPSON J.A.&HUPPLER R.E.(1975).Progress report on the animal assessment program of the Addiction Research Center.Proc. Comm. Problems of Drug Dependence 37th Meeting 110–120.

SAELENS J.K., 1971, The mouse jumping test—a simple screening method to estimate the physical dependence capacity of analgesics, Archs int. Pharmacodyn., 190, 213

10.1111/j.1476-5381.1970.tb10371.x

SWAIN H.H.&SEEVERS M.H.(1975).Evaluation of new compounds for morphine‐like physical dependence in the rhesus monkey.Proc. Comm. Problems of Drug Dependence 37th Meeting Addendum 773–795.

TEIGER D.G., 1974, Induction of physical dependence on morphine, codeine and meperidine in the rat by continuous infusion, J. Pharmac. exp. Ther., 190, 408